Analytical exoglycosidases are transitioning from being largely academic tools to being suitable for glycan analytics in biopharmaceutical manufacturing.
Pauline M. Rudd
Advertisement
Pauline M. Rudd is a visiting investigator at Bioprocessing Technology Institute, Agency for Science, Technology and Research.
Articles by Pauline M. Rudd
Advertisement
Latest Updated Articles
Recent Advances in the Use of Exoglycosidases to Improve Structural Profiling of N-glycans from Biologic DrugsPublished: October 1st 2018 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Orion and Abzena Collaboration Highlights Integrated Antibody Manufacturing Advances
2
SK pharmteco Invests in California Site to Overcome Peptide Purification Bottlenecks
3
Ask the Expert: Commenting on Draft Regulations
4
Challenges, Innovations, and Future Outlook of Biologics Formulations
5
